What is the latest market price for dexmethylphenidate (Azstarys)

The clinical application positioning of dexmethylphenidate (Azstarys) is very clear, that is, it is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults aged 6 years and above. This disease has a high incidence worldwide and is particularly common in children. It is characterized by attention deficit, hyperactivity and impulse control difficulties, which seriously affects learning and social skills. Dexmethylphenidate achieves round-the-clock coverage through a compounding mechanism and avoids the cumbersome need for multiple administrations of traditional short-acting stimulants. Therefore, it is gradually regarded as an important tool in clinical practice to improve patient compliance.

In terms of specific applications, dexmethylphenidate is usually used for ADHD patients who need to maintain concentration in learning and stable behavior for a long time. For children and adolescents, the drug can cover the critical time period from morning to afternoon after school, ensuring continuous concentration in learning activities; for adult patients, especially those in high-pressure work environments, dexmethylphenidate can also help improve the problems of distraction and reduced work efficiency. Therefore, it has a wide range of application groups and adapts to the characteristics of ADHD that require long-term management.

In terms of market price, dexmethylphenidate is not currently available in mainland China, so domestic patients cannot purchase it through regular pharmacies or hospitals, and it is not included in the medical insurance payment system. However, in overseas countries such as the United States, dexmethylphenidate is already sold as an original drug. Public pharmacy prices show that the market price of each box of dexmethylphenidate is approximately US$100 to US$150. The price may vary depending on pharmacy channels, medical insurance coverage, and regions. Although the price is higher than traditional ADHD drugs, many families and patients are still willing to choose it from the perspective of compliance, persistence of drug effect, and patient experience. As it enters more national markets in the future, its price system and medical insurance coverage may change.

Reference materials:https://azstarys.com/